Ex-DHS Official Urges Congress to Keep Hemp THC Ban

A former Trump-era Department of Homeland Security official is pressing lawmakers to hold the line on a proposed federal ban targeting hemp-derived THC products, arguing that failing to close the loophole that allows them to be sold poses a national security risk connected to China. The intervention adds a new, unexpected angle to an already contentious debate over how intoxicating hemp products should be regulated at the federal level.

The comments come as Congress continues to wrestle with how to handle the fallout from the 2018 Farm Bill, which legalized hemp and inadvertently opened the door to a booming market of intoxicating products derived from it, including delta-8 THC, THC-O, and other synthetic or semi-synthetic cannabinoids sold in gas stations, vape shops, and online across much of the country.

What the Former Official Is Arguing

According to the former Homeland Security official, the loosely regulated hemp-derived THC market creates an opening for foreign actors, particularly those tied to China, to exploit supply chains for synthetic cannabinoid production. The argument frames the issue not just as a public health or consumer protection matter, but as a national security concern, tying it to broader anxieties in Washington about Chinese influence over precursor chemicals and unregulated manufacturing pipelines.

This type of argument is notable because it shifts the conversation away from the more familiar framing used by hemp ban advocates, which typically centers on:

• Products marketed to or accessible by minors
• Lack of testing and quality control standards
• Unpredictable potency and unknown health effects
• Confusion between hemp-derived and marijuana-derived cannabinoids

By invoking national security and foreign adversary language, the former official is tapping into a framework that has proven effective in other policy fights in recent years, from concerns over foreign ownership of farmland to restrictions on certain technology platforms.

The Farm Bill Fight Behind the Scenes

This debate is unfolding against the backdrop of the next Farm Bill reauthorization, where a proposed provision would effectively close the loophole that has allowed hemp-derived intoxicants to proliferate. Versions of this language have appeared in earlier drafts and committee proposals, generally by redefining hemp in a way that would exclude products with any detectable amount of THC or other intoxicating cannabinoids, regardless of the plant source.

Supporters of a ban, including some in the marijuana industry, argue that:

• Hemp-derived intoxicants sidestep the licensing, testing, and tax structures that state-legal marijuana businesses must follow
• The current patchwork creates an uneven playing field between regulated cannabis operators and unregulated hemp sellers
• Consumers often cannot tell the difference between a product bought at a licensed dispensary and one bought at a convenience store

Opponents, largely drawn from the hemp industry, counter that a broad ban would wipe out a multibillion-dollar sector that has developed since 2018, eliminate jobs, and push consumers toward unregulated markets rather than solving the underlying safety concerns.

Why the China Framing Matters

Raising a foreign adversary argument in a cannabis policy debate is relatively unusual, but it reflects a broader pattern in Washington where national security rhetoric is increasingly used to build bipartisan support for otherwise divisive regulatory proposals. Whether or not the underlying concern about Chinese-linked supply chains is substantiated, the framing is likely to resonate with lawmakers who might otherwise be reluctant to wade into the hemp versus marijuana industry turf war.

It is worth noting that supply chain concerns involving synthetic cannabinoid precursors are not entirely new. Regulators and industry watchers have previously flagged that many of the chemicals used to convert legal hemp-derived CBD into intoxicating cannabinoids like delta-8 THC originate overseas, though the specifics of sourcing and manufacturing vary widely and are not always well documented publicly.

What This Means for the Industry

For businesses currently operating in the hemp-derived THC space, this development is another signal that federal uncertainty is far from resolved. Companies built around delta-8, delta-10, THCA flower, and similar products should be watching Farm Bill negotiations closely, since the outcome could determine whether their entire business model remains viable.

For state-licensed marijuana operators, the push to close the hemp loophole could be seen as leveling the regulatory playing field, though it would not address the separate and ongoing conflict between state and federal marijuana law.

Key considerations for stakeholders on either side include:

• Monitoring Farm Bill committee activity and proposed definitional changes to hemp
• Watching for state-level responses, since several states have already independently restricted or banned intoxicating hemp products ahead of any federal action
• Understanding that any federal ban would likely include transition periods, exemptions, or enforcement mechanisms that are still being debated

A Patchwork That Predates Any Federal Fix

Regardless of how the federal debate resolves, it is important to remember that hemp and marijuana law already vary significantly by state. Some states have banned delta-8 and similar hemp-derived cannabinoids outright, others regulate them similarly to marijuana products, and some still allow largely unrestricted sales. Anyone involved in growing, selling, or purchasing hemp-derived THC products should confirm the current law in their specific state, since it can change quickly and enforcement approaches differ widely from one jurisdiction to the next.

What to Watch Next

The involvement of a former national security official in this debate suggests that hemp-derived THC regulation is no longer purely a agricultural or public health issue in the eyes of some policymakers. As Farm Bill negotiations continue, expect:

• Continued lobbying from both hemp and marijuana industry groups
• Possible amendments attempting to narrow or broaden any proposed THC definition changes
• Growing use of security and foreign adversary arguments in cannabis-adjacent policy fights

Whether or not the China-focused argument gains real traction in Congress, its emergence signals that the fight over hemp-derived THC products is entering a new phase, one where the stakes are being framed well beyond the cannabis industry itself.

Photo by terry bazemore iii via Pexels.